MARAVAI LIFESCIENCES HOLDINGS, INC. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Maravai Lifesciences Holdings, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2019 to 2023.
  • Maravai Lifesciences Holdings, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$560K, a 97.1% increase year-over-year.
  • Maravai Lifesciences Holdings, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$61.1M, a 67.4% increase from 2022.
  • Maravai Lifesciences Holdings, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$187M, a 17.9% decline from 2021.
  • Maravai Lifesciences Holdings, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$159M, a 399% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$61.1M +$126M +67.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 -$187M -$28.5M -17.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 -$159M -$212M -399% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $53.2M +$57.4M Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$4.17M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.